Sign in
Taking peopleNo phase

The Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder

Key facts

Who runs it
Shanghai Mental Health Center
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
18 people, planned
Started
17 Aug 2025
Expected to end
Jun 2027
Type of study
Interventional, 3 groups
Treatments tested
  • TI stimulation device (nerviox-1000)
Record updated
10 March 2026

Who can take part

Age
18 years to 50 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 15 criteriaShow less

Who can take part

  • 18-50 years old
  • Diagnosis of OCD per DSM-5
  • Y-BOCS score ≥20
  • Have a documented history of at least two adequate trials of selective serotonin reuptake inhibitors (SSRIs). If currently receiving SSRI treatment, the dosage must be stable for at least 8 weeks prior to enrollment
  • With at least 9 years of education

Who cannot take part

  • Received electroconvulsive therapy (ECT) within the past 6 months
  • Received other forms of neuromodulation within the past 2 months(see Item 3 for ECT)
  • MRI-incompatible implants (e.g., pacemaker, stents, cochlear implants)
  • Severe medical illness or seizure risk (e.g., cardiovascular, respiratory conditions)
  • Neurological disorders or history of brain injury/surgery
  • Any DSM-5 diagnosis other than OCD (except OCPD)
  • OCD symptoms too severe to complete assessments
  • Current suicidal risk per investigator judgment
  • Pregnant or planning pregnancy during the study
  • Started structured OCD psychotherapy within 3 months, with expected change during treatment

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study aims to evaluate the efficacy of Temporal Interference (TI) stimulation in treating patients with obsessive-compulsive disorder (OCD) and to explore its potential neural mechanisms using magnetic resonance imaging (MRI) and electroencephalography (EEG).

The 3 groups in the trial

  • Nucleus Accumbens Group(NAcc)-Bed Nucleus of the Stria Terminalis Group(BNST)-Exploratory groupOther group

    Participants assigned to NAcc-BNST group will receive stimulation targeting the NAcc in Phase 1 and the BNST in Phase 2. During the exploratory phase, based on participants' preferences, they will be randomly allocated to receive stimulation targeting one of the following regions: the caudate nucleus, the putamen, or the amygdala.

    Treatment: TI stimulation device (nerviox-1000)

  • Bed Nucleus of the Stria Terminalis Group(BNST)-Nucleus Accumbens Group(NAcc)-Exploratory groupOther group

    Participants assigned to BNST-NAcc group will receive stimulation targeting the BNST in Phase 1 and the NAcc in Phase 2. During the exploratory phase, based on participants' preferences, they will be randomly allocated to receive stimulation targeting one of the following regions: the caudate nucleus, the putamen, or the amygdala.

    Treatment: TI stimulation device (nerviox-1000)

  • Sham Group-NAcc Group or BNST Group-Exploratory groupOther group

    Participants assigned to the Sham-NAcc or Sham-BNST groups will receive sham stimulation in Phase 1, followed by active stimulation targeting the NAcc or the BNST in Phase 2. During the exploratory phase, based on participants' preferences, they will be randomly allocated to receive stimulation targeting one of the following regions: the caudate nucleus, the putamen, or the amygdala.

    Treatment: TI stimulation device (nerviox-1000)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Exploring the Efficacy of Temporal Interference Stimulation in the Treatment of Obsessive-Compulsive Disorder
Fit questions
Built from NCT07113652, who can take part
Record updated
10 March 2026